Picture of Sonoma Pharmaceuticals logo

SNOA — Sonoma Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

U.S. STOCKS ON THE MOVE-Sonoma Pharma, Jaguar Health, Zscaler

* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh

U.S. stock futures dropped on Friday as investors braced for President Donald
Trump's response to China's national security legislation for Hong Kong,
threatening to take the shine off another month of strong gains for Wall Street.
 .N 
    At 07:30 ET, Dow e-minis  1YMc1  were down 0.44% at 25,346. S&P 500 e-minis
 ESc1  were down 0.29% at 3,029.25, while Nasdaq 100 e-minis  NQc1  were down
0.26% at 9,435.5.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Party City Holdco Inc  PRTY.N , up 90.2%
 ** GasLog Partners LP Unit  GLOP.N , up 14.2%
 ** California Resources Corp  CRC.N , up 13.0%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Weidai Ltd  WEI.N , down 10.4%
 ** Apergy Corp  APY.N , down 10.2%
 ** Albemarle Corporation  ALB.N , down 9.3%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Sonoma Pharmaceuticals Inc  SNOA.O , up 94.1%
 ** Jaguar Health Inc  JAGX.O , up 18.3%
 ** Sesen Bio Inc  SESN.O , up 17.5%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Toughbuilt Industries Inc  TBLT.O , down 20.5%
 ** Arca Biopharma Inc  ABIO.O , down 19.9%
 ** Marinus Pharmaceuticals Inc  MRNS.O , down 16.8%
 
 
 ** Sonoma Pharmaceutical Inc  SNOA.O : up 94.1% premarket
 BUZZ-Surges after COVID-19 disinfectant approved in Australia urn:newsml:reuters.com:*:nL4N2DB27B
 
 ** Jaguar Health Inc  JAGX.O : up 18.3% premarket
 BUZZ-Jumps on approval to test diarrhea drug for COVID-19  urn:newsml:reuters.com:*:nL4N2DB2B5
 
 ** Zscaler Inc  ZS.O : up 15.6% premarket
 BUZZ-Jumps as work-from-home trends drive results beat   urn:newsml:reuters.com:*:nL4N2DB287

 (Compiled by Amal S in Bengaluru)
 ((Amal.S@thomsonreuters.com; within U.S.+1 646 223 8780; outside U.S. +91 80
6749 3677;))

Recent news on Sonoma Pharmaceuticals

See all news